Skip to content

A clinical trial of Mentalization Based Therapy treatment for Borderline Personality disorder

Outcome effects of a Mentalization Based Treatment service (Mindsight) for people with Borderline Personality disorder in urban Christchurch: a clinical trial and evaluative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000951853
Enrollment
72
Registered
2012-09-05
Start date
2009-09-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Treatment as usual (TAU) is thought to contribute to the long-standing nature of borderline personality disorder. There is increasing evidence that structured programmes of care, organised around a consistent model of care such as Mentalization Based Treatment, and delivered over the longer-term, are beneficial in reducing self-harm and suicidality; and in reducing service demand and health costs. Additionally, there is evidence that intensive treatment packages produce additional improvements in the long-term. A new MBT service for clients with BPD is introduced in Christchurch. This study will attempt to establish the benefits of investing in a specific treatment approach over more general enhancements to case managment. This comparison will also contribute to the clinical knowledge concerning the efficacy of this treatment approach in real-world scenarios.

Interventions

Mentalization Based Treatment psychotherapy. The intervention group receive a weekly 50 minute individual psychotherapy session with a therapist trained in Mentalization Based Treatment methods. They also attend a 90 minute group psychotherapy session weekly. This is facilitated by 2 MBT trained therapists. They retain a case manager to co-ordinate care and have regular 6 monthly, or greater, reviews by a psychiatrist for medical care. The intervention is applied for a duration of 18 months.

Sponsors

University of Otago, Christchurch
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Diagnosis of Borderline Personality Disorder

Exclusion criteria

Primary diagnosis of psychosis, substance dependence, insufficient ability to speak English to the degree that would inhibit the delivery of structured psychological treatment

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 17, 2026